Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             117 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Anthracyclines versus No Anthracyclines in the Neoadjuvant Strategy for HER2+ Breast Cancer: Real-World Evidence de Pinho, Inês Soares

9 p. 691-698
artikel
2 Appropriateness of Non-vitamin K Antagonist Oral Anticoagulants Dosing According to Different Prescription Guides Used in Belgian Ambulatory Care Delesie, Michiel

9 p. 775-786
artikel
3 Authors’ Reply to: Tocilizumab, Adipokines and Severe Complications of COVID-19 Liu, Bin

9 p. 893-895
artikel
4 Azilsartan Medoxomil Perry, Caroline M.
2012
9 p. 621-639
artikel
5 Basal and Bolus Insulin Dose Changes after Switching Basal Insulin to Insulin Degludec in Patients with Type 1 Diabetes Mellitus: A Pilot Study Hamamoto, Yoshiyuki
2017
9 p. 845-852
artikel
6 Bayesian Network Meta-Analysis for Assessing Adverse Effects of Anti-hepatitis B Drugs Shen, Yi
2019
9 p. 835-846
artikel
7 Botulinum Toxin Type A Overdoses: Analysis of the FDA Adverse Event Reporting System Database Kazerooni, Rashid
2018
9 p. 867-872
artikel
8 Budget Impact Analysis of Oral Fisiogen Ferro Forte® versus Intravenous Iron for the Management of Iron Deficiency in Chronic Kidney Disease in Spain Darbà, Josep
2018
9 p. 801-811
artikel
9 Cerebrospinal Fluid and Clinical Profiles in Adult Type 2–3 Spinal Muscular Atrophy Patients Treated with Nusinersen: An 18-Month Single-Centre Experience Milella, Giammarco

9 p. 775-784
artikel
10 Clinical Characteristics and Implications of Bradycardia in COVID-19 Patients Treated with Remdesivir: A Single-Center Retrospective Cohort Study Schreiber, Ariyon

9 p. 763-774
artikel
11 Coagulant Effect and Tolerability of Yeast-Produced Recombinant Batroxobin in Healthy Adult Subjects Choi, Seuk Keun
2018
9 p. 829-835
artikel
12 Comparing Pioglitazone to Insulin with Respect to Cancer, Cardiovascular and Bone Fracture Endpoints, Using Propensity Score Weights Vallarino, Carlos
2013
9 p. 621-631
artikel
13 Comparison of the Antipsoriatic Effect and Tolerability of Calcipotriol-Containing Products in the Treatment of Psoriasis Vulgaris Using a Modified Psoriasis Plaque Test Queille-Roussel, Catherine
2012
9 p. 613-619
artikel
14 Comparison of the Efficacy and Safety of Direct Oral Anticoagulants and Warfarin After Bioprosthetic Valve Replacements Pasciolla, Stacy

9 p. 839-845
artikel
15 Correction: Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2− Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed Appropriate Fein, Luis

9 p. 707-708
artikel
16 Correction to: Gadobutrol: A Review in Contrast-Enhanced MRI and MRA Scott, Lesley J.
2018
9 p. 881
artikel
17 Correction to: Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features Lyseng-Williamson, Katherine A.
2019
9 p. 915-916
artikel
18 Correction to: Safety, Tolerability, and Pharmacokinetics of GDC-0276, a Novel NaV1.7 Inhibitor, in a First-in-Human, Single- and Multiple-Dose Study in Healthy Volunteers Rothenberg, Michael E.
2019
9 p. 889-890
artikel
19 Cost-Effectiveness Analysis of Levobupivacaine 0.5 %, a Local Anesthetic, Infusion in the Surgical Wound After Modified Radical Mastectomy Ferreira Laso, Lourdes
2015
9 p. 575-582
artikel
20 Cost-Effectiveness Analysis of Rivaroxaban for Treatment of Deep Vein Thrombosis and Pulmonary Embolism in Greece Gourzoulidis, George
2017
9 p. 833-844
artikel
21 Cost of Relapse Management in Patients with Schizophrenia in Italy and Spain: Comparison Between Lurasidone and Quetiapine XR Restelli, Umberto

9 p. 861-871
artikel
22 Cost-Utility Analysis of Fixed-Dose Combination of Indacaterol Acetate Glycopyrronium Bromide and Mometasone Furoate as a Maintenance Treatment in Adult Patients with Asthma Not Adequately Controlled with a Maintenance Combination of a Long-Acting Beta-Agonist and a High Dose of an Inhaled Corticosteroid Who Experienced One or More Asthma Exacerbations in the Previous Year Mangia, Pier Paolo

9 p. 785-794
artikel
23 Cost–Utility Analysis of Pharmacogenetic Testing Based on CYP2C19 or CYP2D6 in Major Depressive Disorder: Assessing the Drivers of Different Cost-Effectiveness Levels from an Italian Societal Perspective Carta, Andrea

9 p. 733-746
artikel
24 Current Recommendations and Novel Strategies for the Management of Skin Toxicities Related to Anti-EGFR Therapies in Patients with Metastatic Colorectal Cancer Annunziata, Maria Carmela
2019
9 p. 825-834
artikel
25 Determinants of Antithrombotic Treatment for Atrial Fibrillation in Octogenarians: Results of the OCTOFA Study Blacher, Jacques
2019
9 p. 891-898
artikel
26 Disproportionality Analysis for the Assessment of Abuse and Dependence Potential of Pregabalin in the French Pharmacovigilance Database Bossard, Jean-Baptiste
2016
9 p. 735-742
artikel
27 Drug–Drug Interactions in Children and Adolescents Receiving Ledipasvir/Sofosbuvir for the Treatment of Hepatitis C Virus Infection Abdullatif, Hala Mohsen
2019
9 p. 857-864
artikel
28 Economic Evaluation of a New Antiemetic Drug — Palonosetron versus Ondansetron Tarricone, Rosanna

9 p. 597-608
artikel
29 Effectiveness and Tolerability of Tapentadol Prolonged Release Compared With Prior Opioid Therapy for the Management of Severe, Chronic Osteoarthritis Pain Steigerwald, Ilona
2013
9 p. 607-619
artikel
30 Effectiveness of Calcitonin Gene-Related Peptide Monoclonal Antibodies in the Prevention of Migraine: A Systematic Review and Meta-Analysis of Observational Cohort Studies Ferreira, Vinicius L.

9 p. 669-680
artikel
31 Effectiveness of Pregabalin as Monotherapy or Combination Therapy for Neuropathic Pain in Patients Unresponsive to Previous Treatments in a Spanish Primary Care Setting Blanco Tarrio, Emilio
2013
9 p. 633-645
artikel
32 Effect of Degarelix, a Gonadotropin-Releasing Hormone Receptor Antagonist for the Treatment of Prostate Cancer, on Cardiac Repolarisation in a Randomised, Placebo and Active Comparator Controlled Thorough QT/QTc Trial in Healthy Men Olsson, Håkan
2017
9 p. 873-879
artikel
33 Effect of Food on the Pharmacokinetics of Piperaquine and Dihydroartemisinin Reuter, Stephanie E.
2015
9 p. 559-567
artikel
34 Effect of Inhaled Corticosteroids on Salival Composition: A Cross-Sectional Study in Patients with Bronchial Asthma Navarrete, Bernardino Alcázar
2015
9 p. 569-574
artikel
35 Effect of Ketoconazole on the Pharmacokinetic Profile of Buprenorphine following Administration of a Once-Weekly Buprenorphine Transdermal System Kapil, Ram P.
2012
9 p. 583-592
artikel
36 Effect of Moderate Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of Roxadustat, an Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Groenendaal-van de Meent, Dorien
2016
9 p. 743-751
artikel
37 Effect of Rifampicin on the Pharmacokinetics of Lenvatinib in Healthy Adults Shumaker, Robert C.
2014
9 p. 651-659
artikel
38 Effects of Chronic Carbamazepine Treatment on the ECG in Patients with Focal Seizures Sathyaprabha, Talakad N.
2018
9 p. 845-851
artikel
39 Effects of Tranexamic Acid on Hemoptysis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Tsai, Yi-San

9 p. 789-797
artikel
40 Efficacy and Safety of a Fixed-Dose Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg in the Treatment of Patients with Vestibular Vertigo: An Individual Patient Data Meta-Analysis of Randomised, Double-Blind, Controlled Clinical Trials Scholtz, Arne W.

9 p. 705-720
artikel
41 Efficacy and Safety of Pitavastatin Versus Simvastatin: A Meta-Analysis of Randomized Controlled Trials Jiang, Zhen
2014
9 p. 599-608
artikel
42 Efficacy and Safety of Sublingual Fentanyl Orally Disintegrating Tablets in Patients with Breakthrough Pain: Multicentre Prospective Study Guitart, Jordi
2013
9 p. 675-683
artikel
43 Efficacy and Safety of Vinpocetine as Part of Treatment for Acute Cerebral Infarction: A Randomized, Open-Label, Controlled, Multicenter CAVIN (Chinese Assessment for Vinpocetine in Neurology) Trial Zhang, Weiwei
2016
9 p. 697-704
artikel
44 Efficacy and Safety Results from a Phase 2, Randomized, Double-Blind Study of Enzalutamide Versus Placebo in Advanced Hepatocellular Carcinoma Ryoo, Baek-Yeol

9 p. 795-808
artikel
45 Efficacy and Tolerability of Oral Compared with Sublingual Ketamine Lozenges as Rescue Analgesics in Adults for Acute Pain: The OSKet Trial Chong, Chui C.

9 p. 817-823
artikel
46 Efficacy of Platelet-rich Plasma for Treating Androgenic Alopecia of Varying Grades Qu, Qian
2019
9 p. 865-872
artikel
47 Efficacy of Statin/Ezetimibe for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Asian Populations: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Bhagavathula, Akshaya Srikanth

9 p. 809-826
artikel
48 Efficacy, Safety, and Systemic Exposure of Once-Daily Indacaterol Acetate in Pediatric Asthma: A Randomized, Double-Blind, Controlled Dose-Finding Study Sekerel, Bulent Enis

9 p. 719-728
artikel
49 Erratum to: Full-dose Perindopril/Indapamide in the Treatment of Difficult-to-Control Hypertension: The FORTISSIMO Study Karpov, Yuri Aleksandrovich
2017
9 p. 889-890
artikel
50 Evaluation of the Single-dose Pharmacokinetics of Bilastine in Subjects with Various Degrees of Renal Insufficiency Lasseter, Kenneth C.
2013
9 p. 665-673
artikel
51 Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2− Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed Appropriate Fein, Luis

9 p. 699-706
artikel
52 Facial Paralysis Following Influenza Vaccination: A Disproportionality Analysis Using the Vaccine Adverse Event Reporting System Database Kamath, Ashwin

9 p. 883-889
artikel
53 Fixed-Dose Ibuprofen/Famotidine: A Review of Its Use to Reduce the Risk of Gastric and Duodenal Ulcers in Patients Requiring NSAID Therapy Deeks, Emma D.
2013
9 p. 689-697
artikel
54 FKB238: A Bevacizumab Biosimilar Syed, Yahiya Y.

9 p. 825-828
artikel
55 Glucose-Lowering Effect of Insulin Degludec is Independent of Subcutaneous Injection Region Nosek, Leszek
2014
9 p. 673-679
artikel
56 High-Dose Levofloxacin in Community-Acquired Pneumonia Lee, Jin Hwa

9 p. 569-576
artikel
57 High-Dose Levofloxacin in Community-Acquired Pneumonia Lee, Jin Hwa
2012
9 p. 569-576
artikel
58 High Doses of Δ9-Tetrahydrocannabinol Might Impair Irinotecan Chemotherapy: A Review of Potentially Harmful Interactions Kopjar, Nevenka

9 p. 775-787
artikel
59 Higher Risk of Sulfonylurea-associated Hypoglycemic Symptoms in Women with Type 2 Diabetes Mellitus Kajiwara, Ayami
2015
9 p. 593-600
artikel
60 Hypertension and Health-Related Quality of Life (HRQoL): Evidence from the US Hispanic Population Riley, Elizabeth
2019
9 p. 899-908
artikel
61 Impact of Disease-Modifying Therapies on the Survival of Patients with Multiple Sclerosis in Taiwan, 1997–2008 Tsai, Ching-Piao
2013
9 p. 647-652
artikel
62 Impact of Formulation on the Pharmacokinetic Profile of Dutasteride Michel, Martin C.
2016
9 p. 769-770
artikel
63 Impact of Formulation on the Pharmacokinetics of Dutasteride: Results from Two Phase I Studies Fossler, Michael
2016
9 p. 763-767
artikel
64 Infant Health and Neurodevelopmental Outcomes Following Prenatal Exposure to Duloxetine Bellantuono, Cesario
2013
9 p. 685-688
artikel
65 Interactions Between CYP3A5*3 and POR*28 Polymorphisms and Lipid Lowering Response with Atorvastatin Wei, Kan-kan
2015
9 p. 583-591
artikel
66 Interventions for Refractory Trigeminal Neuralgia: A Bayesian Mixed Treatment Comparison Network Meta-Analysis of Randomized Controlled Clinical Trials Sridharan, Kannan
2017
9 p. 819-831
artikel
67 Intravenous Busulfan: A Guide to Its Use as Conditioning Treatment before Transplantation of Haematopoietic Progenitor Cells Scott, Lesley J.
2012
9 p. 641-648
artikel
68 Investigation of Potential Drug–Drug Interactions between Peficitinib (ASP015K) and Methotrexate in Patients with Rheumatoid Arthritis Zhu, Tong

9 p. 827-838
artikel
69 Is Molecular Tailored-Therapy Changing the Paradigm for CNS Metastases in Breast Cancer? Di Nunno, Vincenzo

9 p. 757-773
artikel
70 Leflunomide Exposure and Teriflunomide Concentrations up to the Third Trimester of Pregnancy: A Case Report De Klaver, Paul A. G.

9 p. 787-789
artikel
71 Long-Term Safety and Effectiveness of the Xanthine Oxidoreductase Inhibitor, Topiroxostat in Japanese Hyperuricemic Patients with or Without Gout: A 54-week Open-label, Multicenter, Post-marketing Observational Study Ishikawa, Tomohiko

9 p. 847-859
artikel
72 Long-Term Therapeutic Drug Monitoring of Risperidone and Olanzapine Identifies Altered Steady-State Pharmacokinetics Darby, John K.

9 p. 553-564
artikel
73 Loxoprofen: A Review in Pain and Inflammation Greig, Sarah L.
2016
9 p. 771-781
artikel
74 Midostaurin as the Most Likely Cause of Bilateral Adrenal Masses in a Patient with Acute Myeloid Leukemia Schutte, Tim

9 p. 791-797
artikel
75 Moxetumomab Pasudotox in Hairy Cell Leukaemia: A Profile of Its Use Kang, Connie

9 p. 829-834
artikel
76 Multiple-Ascending-Dose Pharmacokinetics and Safety Evaluation of Baicalein Chewable Tablets in Healthy Chinese Volunteers Pang, Hongxian
2016
9 p. 713-724
artikel
77 Nusinersen: The First Option Beyond Supportive Care for Spinal Muscular Atrophy Maharshi, Vikas
2017
9 p. 807-817
artikel
78 OCE-205, A Novel, Selective Vasopressin Receptor Mixed Agonist-Antagonist: Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics from a Phase 1 Study in Healthy Volunteers Bagger, Yu

9 p. 709-717
artikel
79 Open-Label Dose Optimization of Methylphenidate Modified Release Long Acting (MPH-LA): A Post Hoc Analysis of Real-Life Titration from a 40-Week Randomized Trial Huss, Michael
2014
9 p. 639-649
artikel
80 Optimization of Blood Pressure Treatment with Fixed-Combination Perindopril/Amlodipine in Patients with Arterial Hypertension Hatala, Robert
2012
9 p. 603-612
artikel
81 Pattern of Use and Long-Term Safety of Tyrosine Kinase Inhibitors: A Decade of Real-World Management of Chronic Myeloid Leukemia Bettiol, Alessandra
2018
9 p. 837-844
artikel
82 Pharmacodynamics of Insulin Preparations Administered in Different Subcutaneous Injection Sites: Are There Differences Between Healthy Subjects Versus Diabetic Patients? Srinivas, Nuggehally R.
2017
9 p. 881-884
artikel
83 Pharmacokinetic and Exposure Response Analysis of the Double-Blind Randomized Study of Posaconazole and Voriconazole for Treatment of Invasive Aspergillosis Maertens, Johan A.

9 p. 681-690
artikel
84 Pharmacokinetic Bioequivalence of Two Inhaled Tiotropium Bromide Formulations in Healthy Volunteers Algorta, Jaime
2016
9 p. 753-762
artikel
85 Pharmacokinetic Profile of Dextromethorphan Hydrobromide in a Syrup Formulation in Children and Adolescents Guenin, Eric
2014
9 p. 609-616
artikel
86 Pharmacokinetic Properties of Fast-acting Insulin Aspart Administered in Different Subcutaneous Injection Regions: Response to the commentary by Nuggehally R. Srinivas Heise, Tim
2017
9 p. 885-887
artikel
87 Pharmacokinetic Properties of Peramivir After Single and Multiple Intravenous Infusions in Healthy Chinese Volunteers Zhang, Ming
2016
9 p. 705-711
artikel
88 Pharmacokinetics of Imeglimin in Caucasian and Japanese Healthy Subjects Fouqueray, Pascale

9 p. 721-732
artikel
89 Pharmacokinetics of Pregabalin Controlled-Release in Healthy Volunteers: Effect of Food in Five Single-Dose, Randomized, Clinical Pharmacology Studies Chew, Marci L.
2014
9 p. 617-626
artikel
90 Pharmacokinetics, Safety, and Cardiovascular Tolerability of Phenylephrine HCl 10, 20, and 30 mg After a Single Oral Administration in Healthy Volunteers Gelotte, Cathy K.
2015
9 p. 547-558
artikel
91 Potential Role of Allopurinol in Preventing Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention: A Randomized Placebo-Controlled Trial Ghelich Khan, Zahra
2017
9 p. 853-860
artikel
92 Pregabalin Controlled-Release Pharmacokinetics in Healthy Volunteers: Analysis of Four Multiple-Dose Randomized Clinical Pharmacology Studies Chew, Marci L.
2014
9 p. 627-637
artikel
93 Proton Pump Inhibitor Therapy and Hepatic Encephalopathy Risk in Cirrhotic Patients: A Systematic Review with Meta-analysis Shi, Dawei
2019
9 p. 847-856
artikel
94 P2Y12 Inhibitor Monotherapy After a Short Dual Antiplatelet Therapy Versus Standard-Term Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention: A Contemporary Meta-Analysis Ho, Ai-Chen

9 p. 799-808
artikel
95 Real-World Safety and Effectiveness of Controlled-Release Cilostazol in Patients with Symptomatic Peripheral Artery Disease Shin, Woo-young

9 p. 729-738
artikel
96 Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational Study Sangroongruangsri, Sermsiri
2018
9 p. 853-865
artikel
97 Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational Study Sangroongruangsri, Sermsiri

9 p. 853-865
artikel
98 Recombinant Filgrastim (BK0023) Pharmacodynamics and Pharmacokinetics After Single and Multiple Escalating Doses in an Equivalence Study in Healthy Men Stefano, Andrea F. D. Di
2015
9 p. 533-545
artikel
99 Relationship between Telmisartan Dose and Glycaemic Control in Japanese Patients with Type 2 Diabetes Mellitus and Hypertension Hamamoto, Yoshiyuki
2012
9 p. 577-582
artikel
100 RETRACTED ARTICLE: Combination Antiemetic Regimens for Prevention of Postoperative Nausea and Vomiting Fujii, Yoshitaka
2002
9 p. 561-574
artikel
101 Risk of Hepatitis B Reactivation in Patients with Psoriasis on Ustekinumab Ting, Sze-Wen
2018
9 p. 873-880
artikel
102 Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of Inhaled Once-Daily Umeclidinium in Healthy Adults Deficient in CYP2D6 Activity: A Double-Blind, Randomized Clinical Trial Cahn, Anthony
2013
9 p. 653-664
artikel
103 Safety, Tolerability, and Pharmacokinetics of GDC-0276, a Novel NaV1.7 Inhibitor, in a First-in-Human, Single- and Multiple-Dose Study in Healthy Volunteers Rothenberg, Michael E.

9 p. 873-887
artikel
104 Safety, Tolerability, and Pharmacokinetics of GDC-0276, a Novel NaV1.7 Inhibitor, in a First-in-Human, Single- and Multiple-Dose Study in Healthy Volunteers Rothenberg, Michael E.

9 p. 873-887
artikel
105 Safety, Tolerability, and Pharmacokinetics of Ropanicant (SUVN-911), a Novel Alpha4 Beta2 Nicotinic Acetylcholine Receptor (α4β2 nAChR) Antagonist, in Healthy Adult and Elderly Subjects Nirogi, Ramakrishna

9 p. 747-762
artikel
106 Severe Exacerbation of Multiple Sclerosis Following Withdrawal of Fingolimod Fragoso, Yara D.
2019
9 p. 909-913
artikel
107 Signals of Adverse Drug Reactions of Paliperidone Compared to Other Atypical Antipsychotics Using the Korean Adverse Event Reporting System Database Seo, Dong-Eun

9 p. 873-881
artikel
108 Single- and Multiple-Dose Pharmacokinetics, Safety and Tolerability of Lurasidone in Healthy Chinese Subjects Hu, Chaoying
2017
9 p. 861-871
artikel
109 Steady-State Pharmacokinetics of Gabapentin after Administration of a Novel Gastroretentive Extended-Release Formulation in Postmenopausal Women with Vasomotor Symptoms Cowles, Verne E.
2012
9 p. 593-601
artikel
110 The Effect of Food on Tramadol and Celecoxib Bioavailability Following Oral Administration of Co-Crystal of Tramadol–Celecoxib (CTC): A Randomised, Open-Label, Single-Dose, Crossover Study in Healthy Volunteers Encina, Gregorio
2018
9 p. 819-827
artikel
111 The Impact of Non-dopaminergic Medication on Quality of Life in Parkinson’s Disease Oonk, Nicol G. M.

9 p. 809-816
artikel
112 The Pharmacokinetics of Daclatasvir and Asunaprevir Administered in Combination in Studies in Healthy Subjects and Patients Infected with Hepatitis C Virus Eley, Timothy
2014
9 p. 661-671
artikel
113 Therapeutic Use of Nicergoline Winblad, Bengt

9 p. 533-552
artikel
114 Thrombopoietin Levels During Tyrosine Kinase Inhibitor Therapy for Chronic Myeloid Leukemia Hamada, Takashi
2018
9 p. 813-818
artikel
115 Tirbanibulin: Topical Treatment for Actinic Keratosis Dlott, Anna H.

9 p. 751-755
artikel
116 Tocilizumab, Adipokines and Severe Complications of COVID-19 Fioravanti, Antonella

9 p. 891-892
artikel
117 Tolerability and Pharmacokinetics of SYN-004, an Orally Administered β-Lactamase for the Prevention of Clostridium difficile-Associated Disease and Antibiotic-Associated Diarrhea, in Two Phase 1 Studies Roberts, Tracey
2016
9 p. 725-734
artikel
                             117 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland